Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -8 of 8
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Antifungal Use in Oncohematological Neutropenic Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care
Active
2 and over
Other
2005-004973-55
ANTIVORIFUNGOL, NCT00386802
2.
Immediate vs Deferred Empirical Antifungal Treatment With Voriconazole in Neutropenic Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Active
18 and over
Pharmaceutical / Industry
A1501029
NCT00150345
3.
Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
16 and over
Pharmaceutical / Industry
A8851009
NCT00531479
4.
Antifungal Prophylaxis in Pediatric Acute Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
15 and younger
Other
antifungal prophylaxis
Dr. SAMEER BAKHSHI, NCT00624143
Last Modified:
10/23/2007
 
First Published:
10/7/2005
5.
Phase II Study of Voriconazole and Caspofungin Acetate in Immunocompromised Patients With Invasive Fungal Infections
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
18 and over
NCI
OHSU-HEM-0346-L
OHSU-IRB-1379, NCT00238355
6.
Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
18 and over
Other
2006-0536
NCT00418951
Last Modified:
12/12/2007
 
First Published:
12/8/2006
7.
Pilot Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity in Adults and Children
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Biomarker/Laboratory analysis, Natural history/Epidemiology
Active
8 and over
NCI
NCI-06-C-0198
NCI-P6963, NCT00411008
8.
Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Active
15 to 65
Other
VCZ_TDM_Korea
NCT00673348
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute